13 Maoujoud Maoujoud O O Ahid Ahid S S Cherrah Cherrah Y Y The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients Int J Nephrol Renovasc Dis. Here, EPOR is linked to anemia (phenotype).